Patient-preferred treatment attributes such as taste, ease of administration and mouthfeel.1
To help you take a different path on your journey to recovery
- The primary active ingredient in ZUBSOLV is buprenorphine. ZUBSOLV also contains naloxone to deter misuse2
- ZUBSOLV® delivers a comparable concentration of active medication as Suboxone®, a previously approved buprenorphine/naloxone sublingual (under the tongue) tablet3
- There was no increased rate of withdrawal symptoms or cravings when changed from Suboxone film.1
- Do not inject (“shoot-up”) ZUBSOLV. Injecting ZUBSOLV may cause life-threatening infections and other serious health problems. Injecting ZUBSOLV may cause serious withdrawal symptoms such as pain, cramps, vomiting, diarrhea, anxiety, sleep problems, and cravings.
The advanced formulation of ZUBSOLV (buprenorphine and naloxone) sublingual tablets CIII is different than older buprenorphine / naloxone sublingual tablets. This means it can deliver an equivalent concentration of buprenorphine into your system using a smaller dose.3
Because of its highly efficient delivery system, a greater percentage of the medication in ZUBSOLV tablets gets into the bloodstream than with Suboxone tablets.3
Small tablet, lower dose
- ZUBSOLV is a small sublingual tablet
- An overdose, and even death, can happen if you take benzodiazepines, sedatives, tranquilizers, or alcohol while using ZUBSOLV. Ask your healthcare provider what you should do if you are taking one of these.
- Data on file. Orexo US, Inc.
- ZUBSOLV [prescribing information]. Morristown, NJ: Orexo US, Inc.; 2019.
- Fischer A, Jönsson M, Hjelmström P. Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers. Drug Dev Ind Pharm. 2013;1-6. DOI: 10.3109/03639045.2013.846365
Nearly 8 out of 10 patients preferred the menthol taste of ZUBSOLV1
In the largest combination buprenorphine/naloxone opioid dependence trial ever conducted in the United States, 77.5% of patients preferred the taste of ZUBSOLV to Suboxone film.1 ZUBSOLV is the only sublingual tablet for the treatment of opioid dependence that has a menthol flavor.
Fast dissolve time
ZUBSOLV tablets dissolve just as fast as Suboxone film3
- Keep ZUBSOLV in a secure place away from children.
- If a child accidentally takes ZUBSOLV, this is a medical emergency and can result in death. Get emergency help right away.
to take control of your recovery
Everyone is different…so why should treatment plans be the same? RISE was designed to meet your needs and the needs of your support team. Choose from a selection of online tools and resources and build the plan you feel is most helpful to your recovery.
What is ZUBSOLV®?
ZUBSOLV® (buprenorphine and naloxone) sublingual tablet (CIII) is a prescription medicine used to treat adults who are addicted to opioid drugs (either prescription or illegal) as part of a complete treatment program that also includes counseling and behavioral therapy.
IMPORTANT SAFETY INFORMATION
Do not take ZUBSOLV if you are allergic to buprenorphine or naloxone as serious negative side effects, including anaphylactic shock, have been reported.
ZUBSOLV can cause serious and life-threatening breathing problems. Call your healthcare provider right away or get emergency help if (a) you feel faint, dizzy, or confused; (b) your breathing gets much slower than is normal for you; (c) you feel sleepy and uncoordinated; (d) you have blurred vision; (e) you have slurred speech; (f) you cannot think well or clearly; or (g) you have slowed reflexes and breathing. In an emergency, have family members tell the emergency department staff that you are physically dependent on an opioid and are being treated with ZUBSOLV.
ZUBSOLV contains buprenorphine, an opioid that can cause physical dependence with chronic use. Physical dependence is not the same as addiction. Your healthcare provider can tell you more about the difference between physical dependence and addiction. Do not stop taking ZUBSOLV without talking to your healthcare provider. You could become sick with uncomfortable withdrawal signs and symptoms because your body has become used to this medicine.
Your healthcare provider may monitor liver function before and during treatment with ZUBSOLV.
Keep ZUBSOLV in a secure place away from children. If a child accidentally takes ZUBSOLV, this is a medical emergency and can result in death. Get emergency help right away.
The most common side effects of ZUBSOLV include: headache, drug withdrawal syndrome, nausea, decrease in sleep (insomnia), vomiting, pain, increased sweating, swelling of the extremities, and constipation. Tell your healthcare provider about any side effect that bothers you or that does not go away.
Do not switch from ZUBSOLV to other medicines that contain buprenorphine without talking with your healthcare provider. The amount of buprenorphine in a dose of ZUBSOLV is not the same as the amount of buprenorphine in other medicines that contain buprenorphine. Your healthcare provider will prescribe a starting dose of buprenorphine that may be different than other buprenorphine-containing medicines you may have been taking.
ZUBSOLV is not for occasional or “as needed” use. An overdose, and even death, can happen if you take benzodiazepines, sedatives, tranquilizers, or alcohol while using ZUBSOLV. Ask your healthcare provider what you should do if you are taking one of these. You should not drink alcohol while taking ZUBSOLV, as this can lead to loss of consciousness or even death.
Do not inject (“shoot-up”) ZUBSOLV. Injecting ZUBSOLV may cause life-threatening infections and other serious health problems. Injecting ZUBSOLV may cause serious withdrawal symptoms such as pain, cramps, vomiting, diarrhea, anxiety, sleep problems, and cravings.
Before taking ZUBSOLV, tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Before taking ZUBSOLV, tell your healthcare provider if you are pregnant or plan to become pregnant. If you take ZUBSOLV while pregnant, your baby may have signs of withdrawal at birth and that withdrawal is treatable. Talk to your healthcare provider if you are pregnant or plan to become pregnant.
Before taking ZUBSOLV, tell your healthcare provider if you are breastfeeding or plan to breastfeed. ZUBSOLV can pass into your breast milk and may harm your baby. Talk to your healthcare provider about the best way to feed your baby if you take ZUBSOLV. Monitor your baby for increased sleepiness and breathing problems.
Do not drive, operate heavy machinery, or perform any other dangerous activities until you know how ZUBSOLV affects you. Buprenorphine can cause drowsiness and slow reaction times. This may happen more often in the first few weeks of treatment when your dose is being changed, but can also happen if you drink alcohol or take other sedative drugs when you take ZUBSOLV.
ZUBSOLV is a controlled substance (CIII) because it contains buprenorphine, which can be a target for people who abuse prescription medicines or street drugs. Keep your ZUBSOLV in a safe place to protect it from theft. Never give your ZUBSOLV to anyone else; it can cause death or harm them. Selling or giving away this medicine is against the law.
Store ZUBSOLV securely, out of sight and reach of children, and in a location not accessible by others, including visitors at home.
This is not a complete list of negative side effects associated with ZUBSOLV. For a complete list please see full Prescribing Information.
To report negative side effects associated with taking ZUBSOLV, please call 1-888-982-7658. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.